Skip to main content
. 2023 Feb 3;12(1):13. doi: 10.3390/antib12010013
ACAs Anti-centromere autoantibodies
ACE Angiotensin-converting enzyme
ANA Antinuclear antibody
ATAs Anti-topoisomerase I autoantibodies
CREST Calcinosis, RP, esophageal dysmotility, sclerodactyly, and telangiectasia
CRP C-reactive protein
DLCO Diffusing capacity for carbon monoxide
EF Ejection fraction
ESR Erythrocyte sedimentation rate
FVC Forced vital capacity
FEV1 Forced expiratory volume in one second
GAVE Gastric antral venous ectasia
GI Gastro-intestinal tract
HRCT High-resolution computed tomography
ICAP International Consensus on ANA Patterns
IVIG Intravenous immunoglobulin
IIF Indirect immunofluorescence
IIM Idiopathic inflammatory myopathy
ILD Interstitial lung disease
MCTD Mixed connective tissue disease
NSAIDs Nonsteroidal anti-inflammatory drugs
PAP Pulmonary arterial pressure
PFT Pulmonary function test
PMAT Particle multi-analyte technology
RNAP3 Anti-RNA polymerase III
RP Raynaud’s phenomenon
SSc Systemic sclerosis
TLC Total lung capacity
UCTD Undifferentiated connective tissue disease